Header Logo

Connection

Steven Feinstein to Echocardiography

Back to Details
This is a "connection" page, showing publications Steven Feinstein has written about Echocardiography.
Steven Feinstein
Connection Strength
4.584
Echocardiography
  1. Contrast-enhanced ultrasound in pediatric echocardiography. Pediatr Radiol. 2021 Nov; 51(12):2408-2417.
    View in: PubMed
    Score: 0.721
  2. Safety of ultrasound contrast agents in patients with known or suspected cardiac shunts. Am J Cardiol. 2013 Oct 01; 112(7):1039-45.
    View in: PubMed
    Score: 0.413
  3. Comparison of echocardiography using tissue harmonics and contrast harmonics with radionuclide angiography for the assessment of left ventricular function. J Investig Med. 2003 Nov; 51(6):366-72.
    View in: PubMed
    Score: 0.212
  4. New Applications in Echocardiography for Ultrasound Contrast Agents in the 21st Century. Ultrasound Med Biol. 2020 05; 46(5):1071-1081.
    View in: PubMed
    Score: 0.164
  5. Takotsubo cardiomyopathy in a man with no trigger and multiple cardioembolic complications-A rare constellation. Echocardiography. 2019 May; 36(5):975-979.
    View in: PubMed
    Score: 0.154
  6. Contrast echocardiography: review and future directions. Am J Cardiol. 1998 Jun 18; 81(12A):41G-48G.
    View in: PubMed
    Score: 0.146
  7. Contrast echocardiography displays increased subendocardial perfusion after nitroglycerin administration. J Am Soc Echocardiogr. 1997 Apr; 10(3):210-4.
    View in: PubMed
    Score: 0.134
  8. Reduced forward output states affect the left ventricular opacification of intravenously administered Albunex. J Am Soc Echocardiogr. 1997 Jan-Feb; 10(1):25-30.
    View in: PubMed
    Score: 0.132
  9. Optimizing albunex in the left ventricle: an analysis of the technical parameters of four ultrasound systems in canines and humans. J Am Soc Echocardiogr. 1996 Nov-Dec; 9(6):787-94.
    View in: PubMed
    Score: 0.130
  10. Loss of contrast intensity during systole in the left ventricular cavity with the use of the contrast agent Albunex. An analysis of its correlation with pressure and velocity. Invest Radiol. 1996 Jul; 31(7):415-22.
    View in: PubMed
    Score: 0.127
  11. Transient Ischemic Attack Caused by Contrast Echocardiography in a Patient with Platypnea-Orthodeoxia. Echocardiography. 2016 Jan; 33(1):165-6.
    View in: PubMed
    Score: 0.123
  12. Contrast echocardiography. Ultrasound Med Biol. 1994; 20(6):507-15.
    View in: PubMed
    Score: 0.107
  13. A comparison of methods for the detection of myocardial ischemia during noncardiac surgery: automated ST-segment analysis systems, electrocardiography, and transesophageal echocardiography. Anesth Analg. 1992 Nov; 75(5):764-72.
    View in: PubMed
    Score: 0.099
  14. The influence of intravenous Albunex injections on pulmonary arterial pressure, gas exchange, and left ventricular peak intensity. J Am Soc Echocardiogr. 1992 Sep-Oct; 5(5):463-70.
    View in: PubMed
    Score: 0.098
  15. Advances in contrast echocardiography: intraoperative perfusion assessment. Am J Physiol Imaging. 1992 Jul-Dec; 7(3-4):155-9.
    View in: PubMed
    Score: 0.096
  16. Myocardial perfusion: contrast echocardiography perspectives. Am J Cardiol. 1992 Jun 18; 69(20):36H-41H.
    View in: PubMed
    Score: 0.096
  17. The ongoing development of contrast echocardiography: its promise for myocardial perfusion assessment. Am J Card Imaging. 1991 Sep; 5(3):188-91.
    View in: PubMed
    Score: 0.091
  18. Safety and efficacy of a new transpulmonary ultrasound contrast agent: initial multicenter clinical results. J Am Coll Cardiol. 1990 Aug; 16(2):316-24.
    View in: PubMed
    Score: 0.084
  19. A retrospective comparison of mortality in critically ill hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent. JACC Cardiovasc Imaging. 2010 Jun; 3(6):578-85.
    View in: PubMed
    Score: 0.083
  20. Transesophageal echocardiography. J Am Soc Echocardiogr. 1989 Sep-Oct; 2(5):354-7.
    View in: PubMed
    Score: 0.079
  21. Sonicated echocardiographic contrast agents: reproducibility studies. J Am Soc Echocardiogr. 1989 Mar-Apr; 2(2):125-31.
    View in: PubMed
    Score: 0.077
  22. Contrast echocardiography during coronary arteriography in humans: perfusion and anatomic studies. J Am Coll Cardiol. 1988 Jan; 11(1):59-65.
    View in: PubMed
    Score: 0.071
  23. Effect of intracoronary injections of sonicated microbubbles on left ventricular contractility. Am J Cardiol. 1987 Jul 01; 60(1):166-71.
    View in: PubMed
    Score: 0.068
  24. The use of contrast echocardiography for the detection of cardiac shunts. Eur J Echocardiogr. 2007 Jun; 8(3):S2-12.
    View in: PubMed
    Score: 0.067
  25. Echocardiographic contrast agents: effect of microbubbles and carrier solutions on left ventricular contractility. J Am Coll Cardiol. 1987 Apr; 9(4):910-9.
    View in: PubMed
    Score: 0.067
  26. Myocardial perfusion imaging: contrast echocardiography today and tomorrow. J Am Coll Cardiol. 1986 Jul; 8(1):251-3.
    View in: PubMed
    Score: 0.064
  27. Quantitation of echo-contrast effects. Am J Physiol Imaging. 1986; 1(3):124-8.
    View in: PubMed
    Score: 0.061
  28. Advances in contrast two-dimensional echocardiography. Cardiovasc Clin. 1986; 17(1):95-102.
    View in: PubMed
    Score: 0.061
  29. Microbubble dynamics visualized in the intact capillary circulation. J Am Coll Cardiol. 1984 Sep; 4(3):595-600.
    View in: PubMed
    Score: 0.056
  30. The powerful microbubble: from bench to bedside, from intravascular indicator to therapeutic delivery system, and beyond. Am J Physiol Heart Circ Physiol. 2004 Aug; 287(2):H450-7.
    View in: PubMed
    Score: 0.056
  31. Emerging, noninvasive surrogate markers of atherosclerosis. Curr Atheroscler Rep. 2004 Jan; 6(1):60-8.
    View in: PubMed
    Score: 0.054
  32. Two-dimensional contrast echocardiography. I. In vitro development and quantitative analysis of echo contrast agents. J Am Coll Cardiol. 1984 Jan; 3(1):14-20.
    View in: PubMed
    Score: 0.054
  33. Noninvasive surrogate markers of atherosclerosis. Am J Cardiol. 2002 Mar 07; 89(5A):31C-43C; discussion 43C-44C.
    View in: PubMed
    Score: 0.047
  34. Recommendations for the Assessment of Carotid Arterial Plaque by Ultrasound for the Characterization of Atherosclerosis and Evaluation of Cardiovascular Risk: From the American Society of Echocardiography. J Am Soc Echocardiogr. 2020 08; 33(8):917-933.
    View in: PubMed
    Score: 0.042
  35. Visualizing false lumen perfusion using sonicated albumin microspheres in aortic dissection repair: a state of the art application of contrast echocardiography and echoaortography. Crit Care Med. 2000 Jun; 28(6):2147-9.
    View in: PubMed
    Score: 0.042
  36. Contrast echocardiography: current and future applications. J Am Soc Echocardiogr. 2000 Apr; 13(4):331-42.
    View in: PubMed
    Score: 0.041
  37. Use of an intravenous contrast agent (Optison) to enhance echocardiography: efficacy and cost implications. Optison Multicenter Study Group. Am J Manag Care. 1998 Sep 25; 4 Spec No:SP169-76.
    View in: PubMed
    Score: 0.037
  38. Perfusion imaging with contract echocardiography: assessment of the no-reflow phenomenon. Coron Artery Dis. 1995 Aug; 6(8):619-24.
    View in: PubMed
    Score: 0.030
  39. Retrograde cardioplegia does not adequately perfuse the right ventricle. J Thorac Cardiovasc Surg. 1995 Jun; 109(6):1116-24; discussion 1124-6.
    View in: PubMed
    Score: 0.030
  40. Pitfalls in quantitative contrast echocardiography: the steps to quantitation of perfusion. J Am Soc Echocardiogr. 1993 Jul-Aug; 6(4):395-416.
    View in: PubMed
    Score: 0.026
  41. Assessment of retrograde cardioplegia distribution using contrast echocardiography. Ann Thorac Surg. 1991 Oct; 52(4):810-4.
    View in: PubMed
    Score: 0.023
  42. Assessment of myocardial perfusion during CABG surgery with two-dimensional transesophageal contrast echocardiography. Anesthesiology. 1991 Sep; 75(3):433-40.
    View in: PubMed
    Score: 0.023
  43. Contrast echocardiography: a method to visualize changes in regional myocardial perfusion in the dog model for CABG surgery. Anesthesiology. 1990 Feb; 72(2):295-301.
    View in: PubMed
    Score: 0.020
  44. Right heart dysfunction, pulmonary embolism, and paradoxical embolization during liver transplantation. A transesophageal two-dimensional echocardiographic study. Anesth Analg. 1989 Jun; 68(6):777-82.
    View in: PubMed
    Score: 0.019
  45. Myocardial contrast echocardiography: a new asset for the cath lab. Cardiologia. 1989 May; 34(5):389-98.
    View in: PubMed
    Score: 0.019
  46. Contrast echocardiography: effects of microbubbles on coronary blood flow and left ventricular hemodynamics. Am J Physiol Imaging. 1989; 4(4):158-64.
    View in: PubMed
    Score: 0.019
  47. Myocardial risk area and peak gray level measurement by contrast echocardiography: effect of microbubble size and concentration, injection rate, and coronary vasodilation. Am Heart J. 1988 Apr; 115(4):733-9.
    View in: PubMed
    Score: 0.018
  48. Successful left ventricular opacification following peripheral venous injection of sonicated contrast agent: an experimental evaluation. Am Heart J. 1987 Sep; 114(3):570-5.
    View in: PubMed
    Score: 0.017
  49. Contrast echocardiography for evaluation of myocardial perfusion: effects of coronary angioplasty. J Am Coll Cardiol. 1986 Jul; 8(1):232-5.
    View in: PubMed
    Score: 0.016
  50. Physical factors influencing quantitation of two-dimensional contrast echo amplitudes. J Am Coll Cardiol. 1984 Jul; 4(1):157-64.
    View in: PubMed
    Score: 0.014
  51. Computer methods for myocardial contrast two-dimensional echocardiography. J Am Coll Cardiol. 1984 May; 3(5):1212-8.
    View in: PubMed
    Score: 0.014
  52. Myocardial contrast two-dimensional echocardiography: experimental examination at different coronary flow levels. J Am Coll Cardiol. 1984 May; 3(5):1219-26.
    View in: PubMed
    Score: 0.014
  53. Two-dimensional contrast echocardiography. II. Transpulmonary studies. J Am Coll Cardiol. 1984 Jan; 3(1):21-7.
    View in: PubMed
    Score: 0.013
  54. Tissue-type plasminogen activator therapy versus primary coronary angioplasty: impact on myocardial tissue perfusion and regional function 1 month after uncomplicated myocardial infarction. J Am Coll Cardiol. 1998 Feb; 31(2):338-43.
    View in: PubMed
    Score: 0.009
  55. Myocardial distribution of cardioplegic solution after retrograde delivery in patients undergoing cardiac surgical procedures. J Thorac Cardiovasc Surg. 1993 Feb; 105(2):214-21.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.